A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations
Still, they are a joy to behold. She favors animal prints, and I found one of a woman reclining in a hammock. It's a beautiful painting but it's just too depressing to hang anywhere. It's called First Trolley to Van Nuys and shows the center of a town filled with people. I saw a painting he did of a fishing scene but I chose not to buy it. When she died, she left me the painting and it hangs in a place of honor over my fireplace mantle. I spent a lot of time playing in my tree house, that the trees in the picture appealed to me so much. I'll find someone to give it to.Another painting that I admire is called Howard in 1944. One of my favorites that she had was done by John Roeder. It was painted in 1988 by Reverend Howard Finster and is done in vibrant colors and also depicts the buildings in.....

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i."Written by Petra Rattue Copyright: Medical News TodayNot to be reproduced without permission of Medical News Today Additional References Citations . The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs. Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.The authors conclude: "This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers. However, it does appear to increase the risk of skin cancer, including melanoma. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010. Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i."Written by Petra Rattue Copyright: Medical News TodayNot to be reproduced without permission of Medical News Today Additional References Citations . The findings were based on 21 studies and 8 conference Still, they are a joy to behold.I have loved folk art paintings since I was a child. She looked so relaxed, that I could imagine what it felt like to lie there myself. One of my favorites that she had was done by John Roeder. It's called First Trolley to Van Nuys and shows the center of a town filled with people. It is done in vibrant colors and also depicts the buildings in the market like an ice cream parlor and the Hotel Van Nuys. It's a beautiful painting but it's just too depressing to hang anywhere. I personally don't have any of these in my collection, since I like to collect pieces that I can relate to. It was painted in 1988 by Reverend Howard Finster and is done in enamel. I have a friend who collects these and I found one of a woman reclining in a hammock. She favors animal prints, and I found one that depicts leopards and gave it to her for her birthday.The painting that has touched me the most features a sad little girl and is called A Letter From My Mother. I saw a painting he did of a fishing scene but I chose not to buy it. It's too bad my parents didn't let her play football with us. Maybe it's because I spent a lot of time with my grandmother and her house was full of them.There is a subcategory of folk art paintings that depict the world of black Americans. It's of a swamp house on a

ypes of arthritis tpes of arthritis tyes of arthritis typs of arthritis type of arthritis types f arthritis types o arthritis types of rthritis types of athritis types of arhritis types of artritis types of arthitis types of arthrtis types of arthriis types of arthrits types of arthriti rypes of arthritis yypes of arthritis ttpes of arthritis tupes of arthritis tyoes of arthritis typws of arthritis typrs of arthritis typea of arthritis typed of arthritis types if arthritis types pf arthritis types od arthritis types og arthritis types of srthritis types of aethritis types of atthritis types of arrhritis types of aryhritis types of artgritis types of artjritis types of artheitis types of arthtitis types of arthrutis types of arthrotis types of arthriris types of arthriyis types of arthritus types of arthritos types of arthritia types of arthritid ytpes of arthritis tpyes of arthritis tyeps of arthritis typse of arthritis type sof arthritis types fo arthritis types o farthritis types of rathritis types of atrhritis types of arhtritis types of artrhitis types of arthirtis types of arthrtiis types of arthriits types of arthritsi types of arthriti ttypes of arthritis tyypes of arthritis typpes of arthritis typees of arthritis typess of arthritis types oof arthritis types off arthritis types of aarthritis types of arrthritis types of artthritis types of arthhritis types of arthrritis types of arthriitis types of arthrittis types of arthritiis types of arthritiss
A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations